• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 444-458 of 977 results

2030 Exhibit: Ex 2030 Cornford 1982

Document IPR2020-00324, No. 2030-107 Exhibit - Ex 2030 Cornford 1982 (P.T.A.B. Sep. 18, 2020)

cite Cite Document
Analyze

2032 Exhibit: Ex 2032 Fort FL 1984

Document IPR2020-00324, No. 2032-109 Exhibit - Ex 2032 Fort FL 1984 (P.T.A.B. Sep. 18, 2020)

cite Cite Document
Analyze

2038 Exhibit: Ex 2038 Padrick Miranker 2001

Document IPR2020-00324, No. 2038-115 Exhibit - Ex 2038 Padrick Miranker 2001 (P.T.A.B. Sep. 18, 2020)

cite Cite Document
Analyze

2008 Exhibit: EX 2008 Clodfelter 1998 Effects of Non Covalent

Document IPR2020-00324, No. 2008-85 Exhibit - EX 2008 Clodfelter 1998 Effects of Non Covalent (P.T.A.B. Mar. 30, 2020)

cite Cite Document
Analyze

2020 Exhibit: EX 2020 Omnitrope Label 2010

Document IPR2020-00324, No. 2020-97 Exhibit - EX 2020 Omnitrope Label 2010 (P.T.A.B. Mar. 30, 2020)

cite Cite Document
Analyze

2018 Exhibit: EX 2018 Vardar et al 2007

Document IPR2020-00324, No. 2018-95 Exhibit - EX 2018 Vardar et al 2007 (P.T.A.B. Mar. 30, 2020)

cite Cite Document
Analyze

2005 Exhibit: EX 2005 Manning Stability of Protein Pharmaceutic 1989

Document IPR2020-00324, No. 2005-82 Exhibit - EX 2005 Manning Stability of Protein Pharmaceutic 1989 (P.T.A.B. Mar. 30, 2020)

cite Cite Document
Analyze

2013 Exhibit: EX 2013 HUMIRA adalimumab, Abbott Laboratories 01 2003

Document IPR2020-00324, No. 2013-90 Exhibit - EX 2013 HUMIRA adalimumab, Abbott Laboratories 01 2003 (P.T.A.B. Mar. 30, 2020)

cite Cite Document
Analyze

2017 Exhibit: EX 2017 Catanzaro 1991 Propylene Glycol Dermatities

Document IPR2020-00324, No. 2017-94 Exhibit - EX 2017 Catanzaro 1991 Propylene Glycol Dermatities (P.T.A.B. Mar. 30, 2020)

cite Cite Document
Analyze

2006 Exhibit: Ex 2006 Payne 2009 Peptide Formulation Challenges

Document IPR2020-00324, No. 2006-83 Exhibit - Ex 2006 Payne 2009 Peptide Formulation Challenges (P.T.A.B. Mar. 30, 2020)

cite Cite Document
Analyze

2012 Exhibit: EX 2012 US20020061838A1 Peptide Pharmaceutical Formulations

Document IPR2020-00324, No. 2012-89 Exhibit - EX 2012 US20020061838A1 Peptide Pharmaceutical Formulations (P.T.A.B. Mar. 30, 2020)

cite Cite Document
Analyze

1071 Exhibit: Gnanalingham

Document IPR2020-00324, No. 1071-70 Exhibit - Gnanalingham (P.T.A.B. Dec. 19, 2019)

cite Cite Document
Analyze

1031 Exhibit: 175 Publication

Document IPR2020-00324, No. 1031-30 Exhibit - 175 Publication (P.T.A.B. Dec. 19, 2019)

cite Cite Document
Analyze

1021 Exhibit: 098 Publication

Document IPR2020-00324, No. 1021-20 Exhibit - 098 Publication (P.T.A.B. Dec. 19, 2019)

cite Cite Document
Analyze

1069 Exhibit: Noel

Document IPR2020-00324, No. 1069-68 Exhibit - Noel (P.T.A.B. Dec. 19, 2019)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 30 31 32 33 34 ... >>